Dr. Richard Isaacson, United States
January 31, 2022
What makes the Quality of Life endpoint useful in #AlzheimersDisease clinical trials? Watch Dr. Richard Isaacson discuss the QoL-AD.
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.